Portage Biotech Inc (PRTG)
0.4999
+0.24
(+94.51%)
USD |
NASDAQ |
May 31, 16:00
0.37
-0.13
(-25.99%)
After-Hours: 20:00
Portage Biotech Net Income (Quarterly): -39.37M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -39.37M |
| September 30, 2023 | -5.158M |
| June 30, 2023 | -5.919M |
| March 31, 2023 | -94.45M |
| December 31, 2022 | -7.485M |
| September 30, 2022 | -0.949M |
| June 30, 2022 | -1.729M |
| March 31, 2022 | -7.317M |
| December 31, 2021 | -3.512M |
| September 30, 2021 | -2.975M |
| June 30, 2021 | -3.066M |
| March 31, 2021 | -11.50M |
| December 31, 2020 | -1.184M |
| September 30, 2020 | -2.455M |
| June 30, 2020 | -0.696M |
| March 31, 2020 | -1.302M |
| December 31, 2019 | -1.316M |
| September 30, 2019 | -1.273M |
| June 30, 2019 | -1.442M |
| March 31, 2019 | -1.924M |
| December 31, 2018 | -0.307M |
| September 30, 2018 | -0.208M |
| June 30, 2018 | -0.219M |
| March 31, 2018 | 124.77M |
| December 31, 2017 | -0.351M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.341M |
| June 30, 2017 | -0.333M |
| March 31, 2017 | -8.78M |
| December 31, 2016 | -6.073M |
| September 30, 2016 | 33.86M |
| June 30, 2016 | -2.710M |
| March 31, 2016 | -1.145M |
| December 31, 2015 | -2.755M |
| September 30, 2015 | -1.015M |
| June 30, 2015 | -0.7909M |
| March 31, 2015 | -0.9669M |
| December 31, 2014 | -0.6372M |
| September 30, 2014 | -0.7287M |
| June 30, 2014 | -0.7856M |
| March 31, 2014 | -1.666M |
| December 31, 2013 | -0.2922M |
| September 30, 2013 | -0.3483M |
| June 30, 2013 | -3.998M |
| March 31, 2013 | -0.4804M |
| December 31, 2012 | 0.3155M |
| September 30, 2012 | -2.206M |
| June 30, 2012 | 0.8815M |
| March 31, 2012 | -0.5524M |
| December 31, 2011 | -0.4086M |
| September 30, 2011 | -0.6488M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-94.45M
Minimum
Mar 2023
-0.696M
Maximum
Jun 2020
-10.16M
Average
-2.975M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
| Intensity Therapeutics Inc | -4.603M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
| iBio Inc | -3.172M |
| Theriva Biologics Inc | -5.165M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.04M |
| EPS Diluted (Quarterly) | -1.88 |
| Enterprise Value | 3.880M |
| Earnings Yield | -1.67K% |